AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia
Roche’s oncology team has posted another regulatory win.
The pharma giant — allied with AbbVie — says the FDA has approved a combination of Venclexta and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
